February 18, 2015

Natural Product Solutions on Wednesday announced the launch of its new VirMax Blood Sugar Stabilization Formula.

February 3, 2015

Afrezza, an inhaled insulin powder, is now available by prescription in U.S. retail pharmacies, Sanofi and MannKind Corp. announced. The drug is approved by the Food and Drug Administration to control high blood sugar in adults who have type 1 and type 2 diabetes.

 

January 6, 2015

People with type 1 diabetes who intensively control their blood glucose early in their disease are likely to live longer than those who do not.

November 17, 2014

Earlier this year iHealth Lab launched iHealth Align, a mobile blood-glucose monitor that plugs directly into a smartphone, and displays and stores readings using the iHealth Gluco-Smart app. 

October 15, 2014

Sanofi US announced Wednesday the findings of a new survey that reveals striking differences in opinion among various age groups about diabetes and available treatment options.

September 19, 2014

The Food and Drug Administration on Thursday approved Trulicity (dulaglutide), a once-a-week injection to improve blood-sugar levels in adults with Type 2 diabetes. 

September 16, 2014

Roche on Tuesday announced that the Accu-Chek Aviva Expert system is now available by prescription.

September 15, 2014

While Google and Alcon figure out the next wireless 007-style eyewear to help manage diabetes, there are device manufacturers today who are developing next-generation blood-glucose meters. 

September 15, 2014

Thanks to the Centers for Medicare and Medicaid Services’ Five-Star Quality Rating System, the diabetes community stands to play a significant role in how pharmacies think about their patients and their medication adherence programs. 

August 25, 2014

DSN presents a preview of some of the hottest OTC products that appear on the show floor at NACDS Total Store Expo.

August 20, 2014

iHealth Lab recently launched its iHealth Align, one of the world’s smallest, FDA-approved mobile blood-glucose monitors.

August 19, 2014

The Food and Drug Administration has granted tentative approval for Basaglar (insulin glargine injection), which is used to improve glycemic control in adults with Type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with Type 1 diabetes.

August 11, 2014

Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million. 

August 6, 2014

BD Medical, a segment of BD, on Wednesday announced the retail pharmacy launch of BD AutoShield Duo, the only pen needle with patented dual front- and back-end shields that provides greater convenience and safety before and after injecting. 

June 30, 2014

Afrezza, an inhaled insulin powder meant to treat diabetes patients, was approved Friday by the Food and Drug Administration.

June 23, 2014

Almost 70% of adults with Type 1 diabetes never use their blood glucose self-monitoring devices or insulin pumps to download historical data about their blood sugar levels and insulin doses — information that likely would help them manage their disease better.

June 19, 2014

Novo Nordisk on Thursday announced the launch of Levemir FlexTouch (insulin detemir [rDNA origin] injection), a prefilled insulin delivery mechanism, providing a new way for diabetics to administer their insulin.

June 12, 2014

A study published Wednesday on JAMA's website found that diabetes patients taking metformin had a higher risk of all-cause death when insulin was added to their treatment as compared to when sulfonylureas were added to treatment.

March 3, 2014

An international team led by researchers at the Broad Institute and Massachusetts General Hospital has identified mutations in a gene that can reduce the risk of developing Type 2 diabetes, even in people who have such risk factors as obesity and old age, the group announced Sunday.

February 28, 2014

Pharma Supply earlier this week launched NeedleBay, a safe and easy method of organizing and dispensing insulin pen needles and medication.

February 20, 2014

The Food and Drug Administration recently approved two "robotic pills," or pills that place an image camera or ingestible sensors into the gastrointestinal tract, according to a report published earlier this week by the Wall Street Journal.

February 12, 2014

America’s biopharmaceutical research companies currently are developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide, the Pharmaceutical Research and Manufacturers of America announced Tuesday.

January 21, 2014

Novo Nordisk has launched a new insulin pen designed for children with diabetes.

November 1, 2013

The Food and Drug Administration has approved two new insulin pens made by Novo Nordisk, the Danish drug maker said Friday.